Status:
UNKNOWN
Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive Impairment
Lead Sponsor:
Inha University Hospital
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
This study will be done to investigate the feasibility and effectiveness of a 24-week multidomain intervention program consisting of cognitive training, exercise, nutrition management, vascular diseas...
Detailed Description
The physical exercise program will consist of aerobic exercise, exercise to enhance balance and flexibility, muscle-strengthening activities involving major muscle groups, and finger-toe movements. Co...
Eligibility Criteria
Inclusion
- Subjects who completed end-of-study evaluation and participated in the preceding randomized controlled trial (RCT) "Multidomain Interventions Via Face-to-face and Video Communication Platforms in Mild Cognitive Impairment".
- Being able to use the tablet PC through education, or having a person who can help a participant use the tablet PC.
- Having a reliable informant who could provide investigators with the requested information
- Provide written informed consent
Exclusion
- Major psychiatric illness such as major depressive disorders
- Dementia
- Other neurodegenerative disease (e.g., Parkinson's disease)
- Malignancy within 5 years
- Cardiac stent or revascularization within 1 year
- Serious or unstable symptomatic cardiovascular disease
- Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
- Severe loss of vision, hearing, or communicative disability
- Any conditions preventing cooperation as judged by the study physician
- Significant laboratory abnormality that may result in cognitive impairment
- Illiteracy
- Unable to participate in exercise program safely
- Coincident participation in any other intervention trial
Key Trial Info
Start Date :
April 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05301868
Start Date
April 11 2022
End Date
December 31 2023
Last Update
April 13 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Chonnam National University Hospital
Gwangju, South Korea
2
Inha University Hospital
Incheon, South Korea, 22332
3
Ewha Womans Seoul Hospital
Seoul, South Korea
4
Ajou University Hospital
Suwon, South Korea